Panel Discussion: Designing for Success: Smarter Preclinical Strategies in Cell & Gene Therapy
-
Designing with the clinical endpoint in mind: how to reverse-engineer from success to define assays, models, and readouts that matter.
-
Choosing the right modality
-
Assay selection for preclinical validation
-
Designing for manufacturability and scalability